TY - JOUR AU - Munoz, N. AU - Bosch, F. X. AU - Sanjosé, S. AU - Herrero, R. AU - Castellsagué, X. AU - Shah, K. V. PY - 2003 DA - 2003// TI - Epidemiologic classification of human papillomavirus types associated with cervical cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa021641 DO - 10.1056/NEJMoa021641 ID - Munoz2003 ER - TY - JOUR AU - Walboomers, J. M. AU - Jacobs, M. V. AU - Manos, M. M. AU - Bosch, F. X. AU - Kummer, J. A. AU - Shah, K. V. PY - 1999 DA - 1999// TI - Human papillomavirus is a necessary cause of invasive cervical cancer worldwide JO - J Pathol VL - 189 UR - https://doi.org/3.0.CO;2-F DO - 3.0.CO;2-F ID - Walboomers1999 ER - TY - JOUR AU - Dalstein, V. AU - Riethmuller, D. AU - Pretet, J. L. AU - Bail, C. K. AU - Sautiere, J. L. AU - Carbillet, J. P. PY - 2003 DA - 2003// TI - Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study JO - Int J Cancer VL - 106 UR - https://doi.org/10.1002/ijc.11222 DO - 10.1002/ijc.11222 ID - Dalstein2003 ER - TY - JOUR AU - Martel, C. AU - Ferlay, J. AU - Franceschi, S. AU - Vignat, J. AU - Bray, F. AU - Forman, D. PY - 2012 DA - 2012// TI - Global burden of cancers attributable to infections in 2008: a review and synthetic analysis JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70137-7 DO - 10.1016/S1470-2045(12)70137-7 ID - Martel2012 ER - TY - JOUR AU - Herrero, R. AU - Castellsagué, X. AU - Pawlita, M. AU - Lissowska, J. AU - Kee, F. AU - Balaram, P. PY - 2003 DA - 2003// TI - Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/djg107 DO - 10.1093/jnci/djg107 ID - Herrero2003 ER - TY - STD TI - Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. http://globocan.iarc.fr. Accessed 31 Jan 2014. UR - http://globocan.iarc.fr/ ID - ref6 ER - TY - STD TI - Associazione Italiana Registri Tumori (AIRTUM). http://www.registri-tumori.it/cms/. Accessed 16 Jun 2014. UR - http://www.registri-tumori.it/cms/ ID - ref7 ER - TY - STD TI - AIRT working group. I tumori in Italia–Rapporto 2006: I dati di incidenza e mortaltià dei registiri tumori per il periodo 1998–2002 [Incidence and mortality data of the cancer registries, 1998–2002). http://www.registri-tumori.it/cms/?q=Indice2006. Accessed 13 May 2015. UR - http://www.registri-tumori.it/cms/?q=Indice2006 ID - ref8 ER - TY - JOUR AU - Paavonen, J. AU - Naud, P. AU - Salmerón, J. AU - Wheeler, C. M. AU - Chow, S. N. AU - Apter, D. PY - 2009 DA - 2009// TI - Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)61248-4 DO - 10.1016/S0140-6736(09)61248-4 ID - Paavonen2009 ER - TY - JOUR PY - 2007 DA - 2007// TI - Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa061741 DO - 10.1056/NEJMoa061741 ID - ref10 ER - TY - JOUR AU - Wheeler, C. M. AU - Castellsague, X. AU - Garland, S. M. AU - Szarewski, A. AU - Paavonen, J. AU - Naud, P. PY - 2012 DA - 2012// TI - Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70287-X DO - 10.1016/S1470-2045(11)70287-X ID - Wheeler2012 ER - TY - JOUR AU - Lehtinen, M. AU - Paavonen, J. AU - Wheeler, C. M. AU - Jaisamrarn, U. AU - Garland, S. M. AU - Castellsague, X. PY - 2012 DA - 2012// TI - Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(11)70286-8 DO - 10.1016/S1470-2045(11)70286-8 ID - Lehtinen2012 ER - TY - JOUR AU - Brown, D. R. AU - Kjaer, S. K. AU - Sigurdsson, K. AU - Iversen, O. E. AU - Hernandez-Avila, M. AU - Wheeler, C. M. PY - 2009 DA - 2009// TI - The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16–26 years JO - J Infect Dis VL - 199 UR - https://doi.org/10.1086/597307 DO - 10.1086/597307 ID - Brown2009 ER - TY - JOUR AU - Malagón, T. AU - Drolet, M. AU - Boily, M. C. AU - Franco, E. L. AU - Jit, M. AU - Brisson, J. PY - 2012 DA - 2012// TI - Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis JO - Lancet Infect Dis VL - 12 UR - https://doi.org/10.1016/S1473-3099(12)70187-1 DO - 10.1016/S1473-3099(12)70187-1 ID - Malagón2012 ER - TY - STD TI - European Medicines Agency (EMA). Summary of product characteristics (Gardasil). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000703/WC500021142.pdf. Accessed 9 Jul 2014. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000703/WC500021142.pdf ID - ref15 ER - TY - STD TI - European Medicines Agency (EMA). Summary of product characteristics (Cervarix). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000721/WC500024632.pdf. Accessed 14 Mar 2014. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000721/WC500024632.pdf ID - ref16 ER - TY - JOUR AU - Petaja, T. AU - Keranen, H. AU - Karppa, T. AU - Kawa, A. AU - Lantela, S. AU - Siitari-Mattila, M. PY - 2009 DA - 2009// TI - Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10–18 years JO - J Adolesc Health VL - 44 UR - https://doi.org/10.1016/j.jadohealth.2008.10.002 DO - 10.1016/j.jadohealth.2008.10.002 ID - Petaja2009 ER - TY - STD TI - Giambi C. Stato di avanzamento della campagna vaccinale per l’HPV: dati di copertura vaccinale al 31/12/2012–Rapporto Semestrale. http://www.epicentro.iss.it/problemi/hpv/pdf/Aggiornamento_HPV_31122012.pdf. Accessed 16 Jun 2014. UR - http://www.epicentro.iss.it/problemi/hpv/pdf/Aggiornamento_HPV_31122012.pdf ID - ref18 ER - TY - STD TI - Intesa tra il governo, le Regioni et le Proncie autonome concernente “Strategie per l’offerta attiva del vaccino contro l’infezione da HPV in Italia” del 20 dicembre 2007. http://www.statoregioni.it/Documenti/DOC_016696_264%20csr.pdf. Accessed 16 Jun 2014. UR - http://www.statoregioni.it/Documenti/DOC_016696_264%20csr.pdf ID - ref19 ER - TY - STD TI - Intesa tra il Governo, le Regioni e le Province autonome di Trento e Bolzano sul documento recante “Piano Nazionale Prevenzione Vaccinale (PNPV) 2012–2014”.Intesa ai sensi dell’articolo 8, comma 6, della legge 5 giugno 2003, n. 131. http://www.statoregioni.it/Documenti/DOC_035260_54%20csr%20punto%204.pdf. Accessed 16 Jun 2014. UR - http://www.statoregioni.it/Documenti/DOC_035260_54%20csr%20punto%204.pdf ID - ref20 ER - TY - JOUR AU - Panatto, D. AU - Amicizia, D. AU - Tanzi, E. AU - Bianchi, S. AU - Frati, E. R. AU - Zotti, C. M. PY - 2013 DA - 2013// TI - Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? JO - BMC Infect Dis VL - 13 UR - https://doi.org/10.1186/1471-2334-13-575 DO - 10.1186/1471-2334-13-575 ID - Panatto2013 ER - TY - STD TI - Jiang Y, Gauthier A, Postma MJ, Ribassin-Majed L, Largeron N, Bresse X. A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus. Hum Vaccin Immunother. 2013;9. ID - ref22 ER - TY - STD TI - European Centre for Disease Prevention and Control. HPV vaccination in EU countries: review of new evidence. http://www.ecdc.europa.eu/en/activities/sciadvice/_layouts/forms/Review_DispForm.aspx?List=a3216f4c-f040-4f51-9f77-a96046dbfd72&ID=758. Accessed 16 Jun 2014. UR - http://www.ecdc.europa.eu/en/activities/sciadvice/_layouts/forms/Review_DispForm.aspx?List=a3216f4c-f040-4f51-9f77-a96046dbfd72&ID=758 ID - ref23 ER - TY - JOUR AU - Markowitz, L. E. AU - Tsu, V. AU - Deeks, S. L. AU - Cubie, H. AU - Wang, S. A. AU - Vicari, A. S. PY - 2012 DA - 2012// TI - Human papillomavirus vaccine introduction–the first five years JO - Vaccine VL - 30 UR - https://doi.org/10.1016/j.vaccine.2012.05.039 DO - 10.1016/j.vaccine.2012.05.039 ID - Markowitz2012 ER - TY - JOUR AU - Debicki, D. AU - Ferko, N. AU - Demarteau, N. AU - Gallivan, S. AU - Bauch, C. AU - Anonychuk, A. PY - 2008 DA - 2008// TI - Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination JO - Vaccine VL - 26 UR - https://doi.org/10.1016/j.vaccine.2008.02.040 DO - 10.1016/j.vaccine.2008.02.040 ID - Debicki2008 ER - TY - JOUR AU - Demarteau, N. AU - Kriekinge, G. AU - Simon, P. PY - 2013 DA - 2013// TI - Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2013.06.008 DO - 10.1016/j.vaccine.2013.06.008 ID - Demarteau2013 ER - TY - JOUR AU - Goldie, S. J. AU - Kohli, M. AU - Grima, D. AU - Weinstein, M. C. AU - Wright, T. C. AU - Bosch, F. X. PY - 2004 DA - 2004// TI - Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine JO - J Natl Cancer Inst VL - 96 UR - https://doi.org/10.1093/jnci/djh104 DO - 10.1093/jnci/djh104 ID - Goldie2004 ER - TY - JOUR AU - Kim, J. J. AU - Goldie, S. J. PY - 2008 DA - 2008// TI - Health and economic implications of HPV vaccination in the United States JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMsa0707052 DO - 10.1056/NEJMsa0707052 ID - Kim2008 ER - TY - JOUR AU - Jit, M. AU - Chapman, R. AU - Hughes, O. AU - Choi, Y. H. PY - 2011 DA - 2011// TI - Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d5775 DO - 10.1136/bmj.d5775 ID - Jit2011 ER - TY - JOUR AU - Brisson, M. AU - Velde, N. AU - Wals, P. AU - Boily, M. C. PY - 2007 DA - 2007// TI - The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.04.086 DO - 10.1016/j.vaccine.2007.04.086 ID - Brisson2007 ER - TY - JOUR AU - Elbasha, E. H. AU - Dasbach, E. J. AU - Insinga, R. PY - 2007 DA - 2007// TI - Model for assessing human papillomavirus vaccination strategies JO - Emerg Infect Dis VL - 13 UR - https://doi.org/10.3201/eid1301.060438 DO - 10.3201/eid1301.060438 ID - Elbasha2007 ER - TY - STD TI - Osservatorio Nazionale Screening. Quinto rapporto Osservatorio Nazionale Screening (ONS). http://www.osservatorionazionalescreening.it/node/50. Accessed 16 Jun 2014. UR - http://www.osservatorionazionalescreening.it/node/50 ID - ref32 ER - TY - STD TI - Centers for Disease Conrol and Prevention. Press briefing transcript: ACIP recommends all 11–12 year-old males get vaccinated against HPV. http://www.cdc.gov/media/releases/2011/t1025_hpv_12yroldvaccine.html. Accessed 16 Jun 2014. UR - http://www.cdc.gov/media/releases/2011/t1025_hpv_12yroldvaccine.html ID - ref33 ER - TY - STD TI - Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1705-1708. ID - ref34 ER - TY - JOUR AU - Hirth, J. M. AU - Tan, A. AU - Wilkinson, G. S. AU - Berenson, A. B. PY - 2013 DA - 2013// TI - Completion of the human papillomavirus (HPV) vaccine series among males with private insurance between 2006 and 2009 JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2012.12.051 DO - 10.1016/j.vaccine.2012.12.051 ID - Hirth2013 ER - TY - JOUR AU - Laz, T. H. AU - Rahman, M. AU - Berenson, A. B. PY - 2013 DA - 2013// TI - Human papillomavirus vaccine uptake among 9–17 year old males in the United States: the National Health Interview Survey, 2010 JO - Hum Vaccin Immunother VL - 9 UR - https://doi.org/10.4161/hv.23190 DO - 10.4161/hv.23190 ID - Laz2013 ER - TY - JOUR AU - Trim, K. AU - Nagji, N. AU - Elit, L. AU - Roy, K. PY - 2012 DA - 2012// TI - Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011 JO - Obstet Gynecol Int VL - 2012 ID - Trim2012 ER - TY - STD TI - European Centre for Disease Prevention and Control. Introduction of HPV vaccines in European Union countries–an update. 2012. Stockholm. http://ecdc.europa.eu/en/publications/Publications/20120905_GUI_HPV_vaccine_update.pdf. Accessed 16 Jun 2014 UR - http://ecdc.europa.eu/en/publications/Publications/20120905_GUI_HPV_vaccine_update.pdf ID - ref38 ER - TY - JOUR AU - David, M. P. AU - Herck, K. AU - Hardt, K. AU - Tibaldi, F. AU - Dubin, G. AU - Descamps, D. PY - 2009 DA - 2009// TI - Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses JO - Gynecol Oncol VL - 115 UR - https://doi.org/10.1016/j.ygyno.2009.01.011 DO - 10.1016/j.ygyno.2009.01.011 ID - David2009 ER - TY - STD TI - Laprise JF, Drolet M, Boily MC, Jit M, Sauvageau C, Franco EL, et al. Comparing the cost-effectiveness of two- and three-dose schedules of human papillomavirus vaccination: a transmission-dynamic modelling study. Vaccine. 2014. ID - ref40 ER - TY - JOUR AU - Horn, J. AU - Damm, O. AU - Kretzschmar, M. E. E. AU - Deleré, Y. AU - Wichmann, O. AU - Kaufmann, A. M. PY - 2013 DA - 2013// TI - Estimating the long-term effects of HPV vaccination in Germany JO - Vaccine VL - 31 UR - https://doi.org/10.1016/j.vaccine.2013.03.006 DO - 10.1016/j.vaccine.2013.03.006 ID - Horn2013 ER - TY - JOUR AU - Brisson, M. AU - Velde, N. AU - Boily, M. C. PY - 2009 DA - 2009// TI - Economic evaluation of human papillomavirus vaccination in developed countries JO - Public Health Genomics VL - 12 UR - https://doi.org/10.1159/000214924 DO - 10.1159/000214924 ID - Brisson2009 ER - TY - JOUR AU - Chesson, H. W. AU - Ekwueme, D. U. AU - Saraiya, M. AU - Dunne, E. F. AU - Markowitz, L. E. PY - 2011 DA - 2011// TI - The cost-effectiveness of male HPV vaccination in the United States JO - Vaccine VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.07.096 DO - 10.1016/j.vaccine.2011.07.096 ID - Chesson2011 ER - TY - STD TI - Choi YH, Jit M, Gay N, Cox A, Garnett GP, Edmunds WJ. Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine 2009;In Press, Uncorrected Proof. ID - ref44 ER - TY - JOUR AU - Jeurissen, S. AU - Makar, A. PY - 2009 DA - 2009// TI - Epidemiological and economic impact of human papillomavirus vaccines JO - Int J Gynecol Cancer VL - 19 UR - https://doi.org/10.1111/IGC.0b013e3181a130c0 DO - 10.1111/IGC.0b013e3181a130c0 ID - Jeurissen2009 ER - TY - JOUR AU - Kim, J. J. AU - Andres-Beck, B. AU - Goldie, S. J. PY - 2007 DA - 2007// TI - The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting JO - Br J Cancer VL - 97 UR - https://doi.org/10.1038/sj.bjc.6604023 DO - 10.1038/sj.bjc.6604023 ID - Kim2007 ER - TY - JOUR AU - Kim, J. J. AU - Goldie, S. J. PY - 2009 DA - 2009// TI - Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States JO - BMJ VL - 339 UR - https://doi.org/10.1136/bmj.b3884 DO - 10.1136/bmj.b3884 ID - Kim2009 ER - TY - JOUR AU - Marra, F. AU - Cloutier, K. AU - Oteng, B. AU - Marra, C. AU - Ogilvie, G. PY - 2009 DA - 2009// TI - Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review JO - Pharmacoeconomics VL - 27 UR - https://doi.org/10.2165/00019053-200927020-00004 DO - 10.2165/00019053-200927020-00004 ID - Marra2009 ER - TY - JOUR AU - Seto, K. AU - Marra, F. AU - Raymakers, A. AU - Marra, C. A. PY - 2012 DA - 2012// TI - The cost effectiveness of human papillomavirus vaccines: a systematic review JO - Drugs VL - 72 UR - https://doi.org/10.2165/11599470-000000000-00000 DO - 10.2165/11599470-000000000-00000 ID - Seto2012 ER - TY - JOUR AU - Taira, A. V. AU - Neukermans, C. P. AU - Sanders, G. D. PY - 2004 DA - 2004// TI - Evaluating human papillomavirus vaccination programs JO - Emerg Infect Dis VL - 10 UR - https://doi.org/10.3201/eid1011.040222 DO - 10.3201/eid1011.040222 ID - Taira2004 ER - TY - JOUR AU - Zechmeister, I. AU - Blasio, B. F. AU - Garnett, G. AU - Neilson, A. R. AU - Siebert, U. PY - 2009 DA - 2009// TI - Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria JO - Vaccine VL - 27 UR - https://doi.org/10.1016/j.vaccine.2009.06.039 DO - 10.1016/j.vaccine.2009.06.039 ID - Zechmeister2009 ER - TY - JOUR AU - Burger, E. A. AU - Sy, S. AU - Nygard, M. AU - Kristiansen, I. S. AU - Kim, J. J. PY - 2014 DA - 2014// TI - Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0089974 DO - 10.1371/journal.pone.0089974 ID - Burger2014 ER - TY - STD TI - L’Istituto nazionale di statistica. Popolazione residente al 1° Gennaio 2010. http://dati.istat.it/Index.aspx. Accessed 12 Feb 2014. UR - http://dati.istat.it/Index.aspx ID - ref53 ER - TY - JOUR AU - Fahey, M. T. AU - Irwig, L. AU - Macaskill, P. PY - 1995 DA - 1995// TI - Meta-analysis of Pap test accuracy JO - Am J Epidemiol VL - 141 ID - Fahey1995 ER - TY - JOUR AU - Ronco, G. AU - Ghisetti, V. AU - Segnan, N. AU - Snijders, P. J. AU - Gillio-Tos, A. AU - Meijer, C. J. PY - 2005 DA - 2005// TI - Prevalence of human papillomavirus infection in women in Turin, Italy JO - Eur J Cancer VL - 41 UR - https://doi.org/10.1016/j.ejca.2004.07.005 DO - 10.1016/j.ejca.2004.07.005 ID - Ronco2005 ER - TY - JOUR AU - Moscicki, A. B. AU - Hills, N. AU - Shiboski, S. AU - Powell, K. AU - Jay, N. AU - Hanson, E. PY - 2001 DA - 2001// TI - Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.23.2995 DO - 10.1001/jama.285.23.2995 ID - Moscicki2001 ER - TY - JOUR AU - Holowaty, P. AU - Miller, A. B. AU - Rohan, T. AU - To, T. PY - 1999 DA - 1999// TI - Natural history of dysplasia of the uterine cervix JO - J Natl Cancer Inst VL - 91 UR - https://doi.org/10.1093/jnci/91.3.252 DO - 10.1093/jnci/91.3.252 ID - Holowaty1999 ER - TY - JOUR AU - Schlecht, N. F. AU - Platt, R. W. AU - Duarte-Franco, E. AU - Costa, M. C. AU - Sobrinho, J. P. AU - Prado, J. C. PY - 2003 DA - 2003// TI - Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/djg037 DO - 10.1093/jnci/djg037 ID - Schlecht2003 ER - TY - JOUR AU - Melnikow, J. AU - Nuovo, J. AU - Willan, A. R. AU - Chan, B. K. AU - Howell, L. P. PY - 1998 DA - 1998// TI - Natural history of cervical squamous intraepithelial lesions: a meta-analysis JO - Obstet Gynecol VL - 92 ID - Melnikow1998 ER - TY - JOUR AU - Franco, E. L. AU - Villa, L. L. AU - Sobrinho, J. P. AU - Prado, J. M. AU - Rousseau, M. C. AU - Desy, M. PY - 1999 DA - 1999// TI - Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer JO - J Infect Dis VL - 180 UR - https://doi.org/10.1086/315086 DO - 10.1086/315086 ID - Franco1999 ER - TY - JOUR AU - Ho, G. Y. AU - Bierman, R. AU - Beardsley, L. AU - Chang, C. J. AU - Burk, R. D. PY - 1998 DA - 1998// TI - Natural history of cervicovaginal papillomavirus infection in young women JO - N Engl J Med VL - 338 UR - https://doi.org/10.1056/NEJM199802123380703 DO - 10.1056/NEJM199802123380703 ID - Ho1998 ER - TY - JOUR AU - Molano, M. AU - den, B. A. AU - Plummer, M. AU - Weiderpass, E. AU - Posso, H. AU - Arslan, A. PY - 2003 DA - 2003// TI - Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study JO - Am J Epidemiol VL - 158 UR - https://doi.org/10.1093/aje/kwg171 DO - 10.1093/aje/kwg171 ID - Molano2003 ER - TY - JOUR AU - Nobbenhuis, M. A. AU - Helmerhorst, T. J. AU - Brule, A. J. AU - Rozendaal, L. AU - Voorhorst, F. J. AU - Bezemer, P. D. PY - 2001 DA - 2001// TI - Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear JO - Lancet VL - 358 UR - https://doi.org/10.1016/S0140-6736(01)06809-X DO - 10.1016/S0140-6736(01)06809-X ID - Nobbenhuis2001 ER - TY - JOUR AU - Schlecht, N. F. AU - Kulaga, S. AU - Robitaille, J. AU - Ferreira, S. AU - Santos, M. AU - Miyamura, R. A. PY - 2001 DA - 2001// TI - Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JO - JAMA VL - 286 UR - https://doi.org/10.1001/jama.286.24.3106 DO - 10.1001/jama.286.24.3106 ID - Schlecht2001 ER -